{"date":"2026-01-06","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6586-2026-01-06-2034-1cyn967","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"20:34:03","subject":"公告本公司財務主管及會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-01-06 20:34，「公告本公司財務主管及會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-01-06-1903-o9jske","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-01-06","time":"19:03:25","subject":"公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-01-06 19:03，「公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-01-06-1846-k8h4j8","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"18:46:24","subject":"公告本公司115年第一次現金增資認股基準日暨相關作業事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-01-06 18:46，「公告本公司115年第一次現金增資認股基準日暨相關作業事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-01-06-1755-1nuha4r","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-01-06","time":"17:55:40","subject":"公告本公司最近一年累積處分有價證券達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-01-06 17:55，「公告本公司最近一年累積處分有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-01-06-1658-1gow3dd","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"16:58:53","subject":"1. 本公司律師通知對前總經理暨董事沈家平及董事暨前副總經理鄭詩靜進行訴訟（含告訴）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-01-06 16:58，「1. 本公司律師通知對前總經理暨董事沈家平及董事暨前副總經理鄭詩靜進行訴訟（含告訴）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-01-06-1657-z9jcl9","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"16:57:59","subject":"公告本公司115年第一次股東臨時會決議解除董事競業禁止案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-01-06 16:57，「公告本公司115年第一次股東臨時會決議解除董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-01-06-1657-1p2mswa","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"16:57:31","subject":"公告本公司115年第一次股東臨時會補選董事一席當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-01-06 16:57，「公告本公司115年第一次股東臨時會補選董事一席當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-01-06-1657-l0uvpa","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"16:57:01","subject":"公告本公司115年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-01-06 16:57，「公告本公司115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-01-06-1628-19f1wbx","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"16:28:08","subject":"公告本公司辦理114年第1次現金增資認股基準日等相關事宜(補充代收股款及存儲專戶行庫)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-01-06 16:28，「公告本公司辦理114年第1次現金增資認股基準日等相關事宜(補充代收股款及存儲專戶行庫)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-01-06-1558-1518zmd","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"15:58:01","subject":"公告本公司董事長訂定現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-01-06 15:58，「公告本公司董事長訂定現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-01-06-1554-4o37y5","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-01-06","time":"15:54:25","subject":"公告本公司現金增資發行新股申請計畫變更案經金管會核准","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-01-06 15:54，「公告本公司現金增資發行新股申請計畫變更案經金管會核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}